Skip to content
Disclosery

MRA Advisory Group: APH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MRA Advisory Group on APH, newest first. How the timeline and the estimate are built.

MRA Advisory Group held 6,559 APH shares at 2026-09-30 per its 13F-HR filed 2026-10-07.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 6,559 shares
    Change vs previous 13F +1,561 shares

    0.21% of the 13F portfolio, value $552,882.

    13F-HR 0001841816-26-000007 filed by MRA Advisory Group
    Accepted , ingested

  2. period ended2026-06-30
    13F 4,998 shares
    Change vs previous 13F +1,458 shares

    0.32% of the 13F portfolio, value $881,236.

    13F-HR 0001841816-26-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 3,540 shares
    Change vs previous 13F +332 shares

    0.18% of the 13F portfolio, value $447,217.

    13F-HR 0001841816-26-000002 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 3,208 shares
    Change vs previous 13F +148 shares

    0.18% of the 13F portfolio, value $433,564.

    13F-HR 0001841816-26-000001 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 3,060 shares
    Change vs previous 13F -89 shares

    0.17% of the 13F portfolio, value $378,676.

    13F-HR 0001841816-25-000005 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 3,149 shares
    Change vs previous 13F not available

    0.15% of the 13F portfolio, value $310,935.

    13F-HR 0001841816-25-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).